CAPLIPOINT2023-04-012023-06-30 CAPLIPOINT2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member CAPLIPOINT2023-04-012023-06-30in-bse-fin:OneOperatingExpenses02Member CAPLIPOINT2023-06-30 CAPLIPOINT2023-04-012023-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524742 CAPLIPOINT NOTLISTED Caplin Point Laboratories Limited Equity 2023-04-01 2024-03-31 2023-08-07 2023-07-31 INR Crores First quarter 11:45:00 13:45:00 2023-08-07 2023-08-07 Not applicable Single segment Pharmaceuticals 2023-04-01 2023-06-30 Unaudited Consolidated 3953200000.00 120400000.00 4073600000.00 641400000.00 1280400000.00 -135800000.00 350700000.00 2800000.00 113800000.00 550400000.00 2803700000.00 1269900000.00 0.00 1269900000.00 242900000.00 -15300000.00 227600000.00 0.00 1042300000.00 0.00 0.00 0.00 0.00 1042300000.00 -23300000.00 1019000000.00 1034300000.00 8000000.00 1011000000.00 8000000.00 151900000.00 2 13.62 13.55 0.00 0.00 13.62 13.55 0.00 0.00 0.00 Other Expenses 551200000.00 Share of profit (loss) of associates and joint ventures accounted for using equity method -800000.00 0.00 Exchange difference in translating the financial statements of foreign operations -23300000.00 -23300000.00 0.00